Chronic Pain Clinical Trial
Official title:
Analgesic Efficacy of Dry Needling in Fibromyalgia Patients.Influence of Catastrophism in the Successful Intervention
Background: Dry needling trigger point treatment, while painful, has been demonstrated as a
useful tool in fibromyalgia patients for decreasing pain and central sensitization. However,
the current biopsychosocial pain paradigm indicates that fibromyalgia subjects with high
levels of catastrophizing have negative thoughts related with perceived partner responses to
pain, which results in an emotional and physical stress after a painful episode.
Objective: To assess whether catastrophizing could influence the perception of pain during
and after dry needling application.
Study design: A singled-blind randomized controlled trial.
Setting: Department of Medicine, Faculty of Health Sciences, Universitat Jaume I
Methods: Female fibromyalgia patients and number and age-matched female controls will be
recruited and randomly assigned to either a real or a simulated dry needling group. The
Spanish version of the pain catastrophizing scale will be used to assess the catastrophizing
level of each participant before initiating any of the planned interventions. The perceived
pain during and immediately after the dry needling procedure will be measured using the pain
visual analogue scale, [VAS].
Fibromyalgia syndrome (FS) is currently classified as chronic widespread pain with widespread
allodynia (Coster et al., 2008). These symptoms are accompanied by other disorders, such as
sleep disturbance, headaches, morning stiffness, irritable bowel syndrome, interstitial
cystitis, dyspareunia, mood disturbances and depression (Gerwin, 2005). The World Health
Organization recognized FS as a disease in 1992, basing its decision on the diagnostic
criteria of the American College of Rheumatology (ACR) which has recently been criticized and
updated (Wolfe et al., 2011; Wolfe et al., 2010; Wolfe and Hauser, 2011). Depending on the
diagnostic criteria used, the prevalence is from 2% to 8% of the population increasing with
age, with highest values attained between 60 and 70 (Stahl, 2009). In Spain, was estimated
that 2.4% of the population over 20 years old presents the disease, and it is higher in
females than in males (ratio 21:1) (Cordero, 2011).
A central sensitivity syndrome could be the most plausible explanation for chronic widespread
pain affecting people with fibromyalgia syndrome. Although it was suggested this condition
was the sole cause (Yunus, 2007), central sensitization of the nervous system causes the
phenomena of hyperalgesia and allodynia in the individual suffering from chronic pain (Butler
and Moseley, 2003) .
The subject with chronic pain has an altered alarm system; this alteration could be initiated
by a peripheral sensitization (Sarzi-Puttini et al., 2011) activated by the release of
various chemical substances such as substance P, serotonin and bradykinin (Yunus, 2007).
Myofascial trigger points (MTrPs) are able to maintain this peripheral sensitization
(Affaitati et al., 2011; Ge et al., 2010) by triggering the spontaneous pain patterns
experienced by a patient with fibromyalgia syndrome (Ge et al., 2011).
MTrPs contain algogenic substances capable of generating changes in the intensity of pain.
Differences in the concentration of these substances between healthy muscle and MTrPs (Shah
et al., 2005) have been shown. One of the most effective techniques for the treatment of
MTrPs is dry needling (Mayoral, 2010), because it alters the chemical environment of the
MTrPs, thus decreasing their sensitization (Dommerholt, 2011). However, there are as until no
few studies that have examined the effectiveness of this technique in patients with FS (Chou
et al., 2008; Staud, 2006). Moreover, in these patients the perception of pain during and
after treatment can be influenced not only by central sensitization, but also by psychosocial
variables.
Catastrophization, considered to be the basic psychological construction concerning the
perception of pain intensity, is a cognitive and emotional process encompassing magnification
of pain-related stimuli, feelings of helplessness, and a generally pessimistic orientation
(Labus et al., 2003; Rodero et al., 2010). This catastrophization, understood as a set of
negative emotions and cognitive processes, is a risk factor in fibromyalgia and leads to an
increase in symptoms, health status warning, symptoms of helplessness and pessimism (Alegre
de Miquel and Sellas Fernandez, 2008; Sullivan et al., 2001).
These negative thoughts lead to alterations in the function of the descending inhibitory
pathways that modulate pain (Wideman and Sullivan, 2011) producing an increase in the pain's
intensity and exaggerated pain behavior (Wideman and Sullivan, 2012). Several lines of
research suggest that this psychological construct is an indicator of poor results obtained
from various treatments (surgical, pharmacological and psychological interventions in pain
management) (Sullivan et al., 2009; Mankovsky et al., 2012; Sullivan et al., 2005).
Catastrophizing is an important factor in the pathophysiological FM, which also influences
the perception of pain and the effects of the various treatments mentioned above. Several
studies have shown that catastrophizing increases attention at the site of injury and
increases the fear of pain that patient refers (McMahon et al., 2013; Sullivan et al., 2001).
However, how this psychological construct may influence both factors - the treatment
effectiveness of MTrPs by dry needling and the perception of pain during this treatment - is
still unknown.
Subjects who experience high levels of catastrophizing have been demonstrated as having
increased emotional and physical stress in response to a painful episode. It would therefore
be interesting to analyze whether high levels of catastrophizing may influence and be related
with high levels of perceived pain during and after dry needling treatment.
The main objective of our study is to assess whether catastrophizing could influence the
perception of pain during and after dry needling application.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|